vs
太平洋生物科学（ASMB）与Simulations Plus, Inc.（SLP）财务数据对比。点击上方公司名可切换其他公司
Simulations Plus, Inc.的季度营收约是太平洋生物科学的1.7倍（$18.4M vs $10.8M），Simulations Plus, Inc.净利率更高（3.7% vs -85.2%，领先88.9%），太平洋生物科学同比增速更快（57.6% vs -2.7%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
ASMB vs SLP — 直观对比
营收规模更大
SLP
是对方的1.7倍
$10.8M
营收增速更快
ASMB
高出60.3%
-2.7%
净利率更高
SLP
高出88.9%
-85.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $18.4M |
| 净利润 | $-9.2M | $676.0K |
| 毛利率 | — | 59.1% |
| 营业利润率 | -100.9% | 3.9% |
| 净利率 | -85.2% | 3.7% |
| 营收同比 | 57.6% | -2.7% |
| 净利润同比 | 4.3% | 228.2% |
| 每股收益（稀释后） | $-0.72 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBSLP
| Q4 25 | — | $18.4M | ||
| Q3 25 | $10.8M | $17.5M | ||
| Q2 25 | $9.6M | $20.4M | ||
| Q1 25 | $9.4M | $22.4M | ||
| Q4 24 | $7.4M | $18.9M | ||
| Q3 24 | $6.8M | $18.7M | ||
| Q2 24 | $8.5M | $18.5M | ||
| Q1 24 | $5.8M | $18.3M |
净利润ASMBSLP
| Q4 25 | — | $676.0K | ||
| Q3 25 | $-9.2M | $-681.0K | ||
| Q2 25 | $-10.2M | $-67.3M | ||
| Q1 25 | $-8.8M | $3.1M | ||
| Q4 24 | — | $206.0K | ||
| Q3 24 | $-9.6M | $843.0K | ||
| Q2 24 | $-11.2M | $3.1M | ||
| Q1 24 | $-9.1M | $4.0M |
毛利率ASMBSLP
| Q4 25 | — | 59.1% | ||
| Q3 25 | — | 56.4% | ||
| Q2 25 | — | 64.0% | ||
| Q1 25 | — | 58.5% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.2% |
营业利润率ASMBSLP
| Q4 25 | — | 3.9% | ||
| Q3 25 | -100.9% | 3.8% | ||
| Q2 25 | -115.2% | -364.5% | ||
| Q1 25 | -105.5% | 12.1% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | -160.1% | -6.2% | ||
| Q2 24 | -143.0% | 10.1% | ||
| Q1 24 | -185.5% | 24.3% |
净利率ASMBSLP
| Q4 25 | — | 3.7% | ||
| Q3 25 | -85.2% | -3.9% | ||
| Q2 25 | -105.9% | -330.6% | ||
| Q1 25 | -93.6% | 13.7% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | -140.4% | 4.5% | ||
| Q2 24 | -130.7% | 16.9% | ||
| Q1 24 | -156.9% | 22.0% |
每股收益（稀释后）ASMBSLP
| Q4 25 | — | $0.03 | ||
| Q3 25 | $-0.72 | $-0.03 | ||
| Q2 25 | $-1.33 | $-3.35 | ||
| Q1 25 | $-1.17 | $0.15 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-1.51 | $0.04 | ||
| Q2 24 | $-1.98 | $0.15 | ||
| Q1 24 | $-1.66 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $35.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $127.1M |
| 总资产 | $240.0M | $137.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBSLP
| Q4 25 | — | $35.7M | ||
| Q3 25 | $22.5M | $32.4M | ||
| Q2 25 | $24.0M | $28.4M | ||
| Q1 25 | $23.4M | $21.4M | ||
| Q4 24 | $38.3M | $18.2M | ||
| Q3 24 | $28.5M | $20.3M | ||
| Q2 24 | $19.2M | $119.0M | ||
| Q1 24 | $18.7M | $108.5M |
股东权益ASMBSLP
| Q4 25 | — | $127.1M | ||
| Q3 25 | $182.7M | $124.8M | ||
| Q2 25 | $18.1M | $123.8M | ||
| Q1 25 | $27.1M | $189.5M | ||
| Q4 24 | $33.4M | $184.7M | ||
| Q3 24 | $26.0M | $182.4M | ||
| Q2 24 | $34.7M | $180.9M | ||
| Q1 24 | $32.6M | $177.0M |
总资产ASMBSLP
| Q4 25 | — | $137.8M | ||
| Q3 25 | $240.0M | $131.9M | ||
| Q2 25 | $80.8M | $134.4M | ||
| Q1 25 | $99.0M | $201.4M | ||
| Q4 24 | $119.2M | $196.9M | ||
| Q3 24 | $100.3M | $196.6M | ||
| Q2 24 | $115.3M | $192.7M | ||
| Q1 24 | $119.9M | $194.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $4.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 6.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBSLP
| Q4 25 | — | $4.2M | ||
| Q3 25 | $-15.1M | $5.6M | ||
| Q2 25 | $-16.8M | $8.1M | ||
| Q1 25 | $-23.4M | $5.7M | ||
| Q4 24 | $-51.1M | $-1.3M | ||
| Q3 24 | $-15.2M | $1.7M | ||
| Q2 24 | $-17.1M | $5.7M | ||
| Q1 24 | $-18.4M | $5.8M |
自由现金流ASMBSLP
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | $5.3M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | $-51.1M | $-1.4M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | $-17.1M | $5.6M | ||
| Q1 24 | $-18.4M | $5.4M |
自由现金流率ASMBSLP
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | 30.5% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 25.0% | ||
| Q4 24 | -695.2% | -7.2% | ||
| Q3 24 | — | 8.8% | ||
| Q2 24 | -200.6% | 30.0% | ||
| Q1 24 | -317.7% | 29.4% |
资本支出强度ASMBSLP
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.4% | 1.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.4% | 0.5% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.2% | 0.6% | ||
| Q1 24 | 0.2% | 2.4% |
现金转化率ASMBSLP
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | -6.18× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
